What is Meniere’s disease?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 17, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

What is Ménière's Disease?

Ménière's disease is an inner ear disorder characterized by recurrent spontaneous vertigo attacks lasting 20 minutes to 12 hours, accompanied by fluctuating low- to mid-frequency sensorineural hearing loss, tinnitus, and aural fullness in the affected ear. 1

Core Clinical Features

The diagnosis requires all three components 1:

  • Two or more spontaneous vertigo attacks, each lasting 20 minutes to 12 hours
  • Audiometrically documented fluctuating low- to mid-frequency sensorineural hearing loss in the affected ear on at least one occasion before, during, or after a vertigo episode
  • Fluctuating aural symptoms (hearing loss, tinnitus, or ear fullness) in the affected ear

The vertigo is specifically a sensation of rotary spinning or self-motion when neither is occurring, distinct from simple imbalance or unsteadiness 1.

Underlying Pathophysiology

While the exact cause remains unclear, Ménière's disease is associated with endolymphatic hydrops—excessive accumulation of endolymph fluid in the inner ear's membranous labyrinth 1. This fluid buildup causes damage to ganglion cells and disrupts normal inner ear function 2. However, endolymphatic hydrops may represent a secondary manifestation rather than the primary driver, potentially resulting from endolymphatic sac dysfunction 3.

The etiology is multifactorial, involving genetic predisposition, autoimmune processes, viral infections, trauma, allergies, and vascular mechanisms 4, 5.

Natural History and Demographics

Ménière's disease typically presents in adults between ages 40-70 years 1. The course is unpredictable with sporadic, unpredicted attacks 1. On average, the disease stabilizes with no further vestibular attacks approximately 8 years after symptom onset, though this is highly variable 6.

Critical caveat: While hearing may worsen initially, it can stabilize over time, though some patients develop permanent sensorineural hearing loss 1. Some patients in later stages experience drop attacks (Tumarkin's Otolithic Crisis)—sudden falls without warning or loss of consciousness 1.

Diagnostic Approach

Physical examination is typically unremarkable 1. Diagnosis relies on:

  • Audiometry: May show low- to mid-frequency sensorineural hearing loss, though it can be normal between attacks
  • Vestibular testing: Video/electronystagmography evaluates vestibular function
  • MRI with contrast: Rules out alternative diagnoses (typically normal in Ménière's disease); newer protocols can visualize endolymphatic hydrops directly 7
  • Electrocochleography: Measures electrical responses of the cochlea

Conventional imaging is typically normal, which helps exclude other pathology 1.

Impact on Quality of Life

Ménière's disease profoundly affects quality of life beyond the physical symptoms 1. Patients experience:

  • Chronic fatigue and malaise during and between attacks
  • Difficulty with hearing and attention
  • Anticipatory anxiety about future attacks even during symptom-free periods
  • Impaired social participation and vitality 7

The unpredictable nature of attacks creates significant psychological burden, as patients cannot anticipate when disabling vertigo will occur 1.

Management Goals

Treatment aims to prevent or reduce vertigo attack severity and frequency, relieve or prevent hearing loss, tinnitus, and aural fullness, and improve overall quality of life 1. There is no cure for Ménière's disease—all therapies are symptom-focused 1.

The management approach progresses from least to most aggressive 1:

  1. Dietary modifications: Low-sodium diet (1500-2300 mg daily per American Heart Association guidelines), limit alcohol and caffeine
  2. Medications: Diuretics, antivertigo medications for acute attacks, antihistamines, betahistine
  3. Noninvasive therapies: Vestibular rehabilitation, hearing aids
  4. Intratympanic injections: Steroids or gentamicin through the eardrum
  5. Surgery: Endolymphatic sac decompression (hearing-sparing), vestibular nerve section (hearing-sparing), or labyrinthectomy (hearing-ablative)

Important clinical consideration: Treatment selection depends critically on whether hearing is "usable" or not—nonablative procedures are preferred when serviceable hearing remains 1.

Triggers and Modifiable Factors

Triggers vary significantly between patients and may include 1:

  • Sodium intake
  • Caffeine and alcohol consumption
  • Stress
  • Weather changes
  • Allergies

Patients benefit from keeping symptom diaries to identify personal triggers 1.

References

Guideline

clinical practice guideline: ménière's disease.

Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery, 2020

Research

Meniere's disease.

Nature reviews. Disease primers, 2016

Research

Approach to Ménière disease management.

Canadian family physician Medecin de famille canadien, 2019

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.